Anti-biofilm potential of Lactobacillus plantarum Y3 culture and its cell-free supernatant against multidrug-resistant uropathogen Escherichia coli U12
- PMID: 35531251
- PMCID: PMC9073023
- DOI: 10.1016/j.sjbs.2022.01.014
Anti-biofilm potential of Lactobacillus plantarum Y3 culture and its cell-free supernatant against multidrug-resistant uropathogen Escherichia coli U12
Abstract
Uropathogens develop biofilms on urinary catheters, resulting in persistent and chronic infections that are associated with resistance to antimicrobial therapy. Therefore, the current study was performed to control biofilm-associated urinary tract infections through assaying the anti-biofilm ability of lactic acid bacteria (LAB) against multidrug-resistant (MDR) uropathogens. Twenty LAB were obtained from pickles and fermented dairy products, and screened for their anti-biofilm and antimicrobial effects against MDR Escherichia coli U12 (ECU12). Lactobacillus plantarum Y3 (LPY3) (MT498405), showed the highest inhibitory effect and biofilm production. Pre-coating of a microtitre plate with LPY3 culture was more potent than co-incubation. Pre-coating with LPY3 culture generated a higher anti-biofilm effect with an adherence of 14.5% than cell free supernatant (CFS) (31.2%). Anti-biofilm effect of CFS was heat stable up to 100 °C with higher effect at pH 4-6. Pre-coating urinary catheter with LPY3 culture reduced the CFU/cm2 of ECU12 attached to the catheter for up to seven days. Meanwhile, CFS reduced the ECU12 CFU/cm2 for up to four days. Scanning electron microscope confirmed the reduction of ECU12 adherence to catheters after treatment with CFS. Therefore, Lactobacillus plantarum can be applied in medical devices as prophylactic agent and as a natural biointervention to treat urinary tract infections.
Keywords: Adherence; BHI, brain heart infusion; Biofilms; CAUTI, catheter associated urinary tract infection; CFU, colony forming unit; CRA, congo red agar; CV, crystal violet; LAB, Lactic acid bacteria; LPY3, Lactobacillus plantarum Y3; Lactic acid bacteria; MRS, De Man, Rogosa, and Sharpe; PBS, phosphate-buffered saline; SEM, scanning electron microscope.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures






Similar articles
-
Antibacterial and antibiofilm effects of silver nanoparticles against the uropathogen Escherichia coli U12.Saudi J Biol Sci. 2022 Nov;29(11):103457. doi: 10.1016/j.sjbs.2022.103457. Epub 2022 Sep 23. Saudi J Biol Sci. 2022. PMID: 36267912 Free PMC article.
-
Antibacterial and anti-biofilm activities of probiotic Lactobacillus plantarum against Listeria monocytogenes isolated from milk, chicken and pregnant women.Front Microbiol. 2023 Jul 19;14:1201201. doi: 10.3389/fmicb.2023.1201201. eCollection 2023. Front Microbiol. 2023. PMID: 37538844 Free PMC article.
-
Characterization and potential oral probiotic properties of Lactobacillus plantarum FT 12 and Lactobacillus brevis FT 6 isolated from Malaysian fermented food.Arch Oral Biol. 2022 Nov;143:105515. doi: 10.1016/j.archoralbio.2022.105515. Epub 2022 Aug 19. Arch Oral Biol. 2022. PMID: 36084351
-
Urinary Catheters Coated with a Novel Biofilm Preventative Agent Inhibit Biofilm Development by Diverse Bacterial Uropathogens.Antibiotics (Basel). 2022 Oct 30;11(11):1514. doi: 10.3390/antibiotics11111514. Antibiotics (Basel). 2022. PMID: 36358169 Free PMC article.
-
A strategy to control colonization of pathogens: embedding of lactic acid bacteria on the surface of urinary catheter.Appl Microbiol Biotechnol. 2020 Nov;104(21):9053-9066. doi: 10.1007/s00253-020-10903-6. Epub 2020 Sep 19. Appl Microbiol Biotechnol. 2020. PMID: 32949279 Review.
Cited by
-
Antibacterial and antibiofilm effects of silver nanoparticles against the uropathogen Escherichia coli U12.Saudi J Biol Sci. 2022 Nov;29(11):103457. doi: 10.1016/j.sjbs.2022.103457. Epub 2022 Sep 23. Saudi J Biol Sci. 2022. PMID: 36267912 Free PMC article.
-
Lactiplantibacillus plantarum Postbiotics Suppress Salmonella Infection via Modulating Bacterial Pathogenicity, Autophagy and Inflammasome in Mice.Animals (Basel). 2023 Oct 14;13(20):3215. doi: 10.3390/ani13203215. Animals (Basel). 2023. PMID: 37893938 Free PMC article.
-
Lactobacillus acidophilus (strain Scav) postbiotic metabolites reduce infection and modulate inflammation in an in vivo model of Pseudomonas aeruginosa wound infection.J Appl Microbiol. 2025 Mar 3;136(3):lxaf061. doi: 10.1093/jambio/lxaf061. J Appl Microbiol. 2025. PMID: 40068933 Free PMC article.
-
In Vitro Evaluation of Probiotic Properties and Anti-Pathogenic Effects of Lactobacillus and Bifidobacterium Strains as Potential Probiotics.Foods. 2024 Jul 22;13(14):2301. doi: 10.3390/foods13142301. Foods. 2024. PMID: 39063385 Free PMC article.
-
Postbiotics Production of Candidate-Probiotic Lactiplantibacillus plantarum AC131 with Renewable Bio Resources.Life (Basel). 2023 Oct 2;13(10):2006. doi: 10.3390/life13102006. Life (Basel). 2023. PMID: 37895388 Free PMC article.
References
-
- Almalki M.A., Varghese R. Prevalence of catheter associated biofilm producing bacteria and their antibiotic sensitivity pattern. J. King Saud. Univ. Sci. 2020;32(2):1427–1433.
-
- Barbosa J., Albano H., Silva B., Almeida M.H., Nogueira T., Teixeira P. Characterization of a Lactiplantibacillus plantarum R23 isolated from arugula by whole-genome sequencing and its bacteriocin production ability. Int. J. Environ. Res. Public Health. 2021;18(11):5515. doi: 10.3390/ijerph18115515. - DOI - PMC - PubMed
-
- Bose S., Khodke M., Basak S., Mallick S.K. Detection of biofilm producing staphylococci: need of the hour. J. Clin. Diagn. Res. 2009;3(6):1915–11912.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous